RegInfo: The international database of regulated information of listed companies

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
- Remgro
- RICHEMONT
- RMB Holdings
- Sanlam
- Sasol
- Shoprite
- Standard Bank Group
- Tiger Brands
- Vodacom Group
- WOOLWORTHS
> TA 25
Israel - TA 25
- AVNER OIL
- AZRIELI GROUP
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- ICL
- IFF
- ISRAEL CORP
- KENON
- LEUMI
- MIGDAL INSURANCE
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- OSEM
- PAZ OIL
- PERRIGO
- POALIM
- STRAUSS GROUP
- TEVA

Europe

PERIODIC INFORMATION

ANNUAL FINANCIAL REPORT	HALF-YEAR FINANCIAL	QUARTERLY INFORMATION
ARYZTA AG DORMAKABA LOGITECH INTERNATIONAL	TEMENOS GROUP PARTNERS GROUP HELVETIA GROUP	LOGITECH INTERNATIONAL DUFRY ADECCO
More documents (800)	More documents (669)	More documents (540)
20F	AGM	INTERNAL CONTROL
UBS ABB Ltd NOVARTIS	LAFARGE HOLCIM GAM HOLDING GAM HOLDING	ROCHE LAFARGE HOLCIM LAFARGE HOLCIM
More documents (4)	More documents (87)	More documents (29)
ANNUAL INFO MEMO ART
ARYZTA AG
More documents (1)

PERMANENT INFORMATION

2019.10.22 | 07:00 | Permanent Information Releases / General Company News

NOVARTIS

Novartis verzeichnet ein weiteres starkes Quartal mit zweistelligem Umsatz-wachstum und höherer Kerngewinnmarge1; Umsatz- und Gewinnerwartung für 2019 angehoben; US-Einführung von Beovu - HTML (w)

2019.10.22 | 07:00 | Permanent Information Releases / General Company News

NOVARTIS

Novartis delivered another strong quarter with double digit sales growth and core1 margin expansion; 2019 sales and profit guidance raised; Beovu launched in US - HTML (w)

2019.10.22 | 07:00 | Permanent Information Releases / General Company News

NOVARTIS

Novartis, encore un fort trimestre: croissance à deux chiffres des ventes et expansion de la marge core1; hausse des prévisions de chiffre d'affaires et de résultat en 2019; Beovu lancé aux USA - HTML (w)

2019.10.21 | 07:00 | Permanent Information Releases / General Company News

ROCHE

Roche's Tecentriq in combination with Avastin increased overall survival and progression-free survival in people with unresectable hepatocellular carcinoma - HTML (w)

2019.10.18 | 07:00 | Permanent Information Releases / General Company News

ROCHE

Roche announces FDA approval of Xofluza (baloxavir marboxil) for people at high risk of developing influenza-related complications - HTML (w)

More documents (3333)

Financial transactions

2019.07.31 | 07:00 | Public offerings / Press Releases during Offer Period

ROCHE

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. - HTML (w)

2019.06.20 | 04:30 | Public offerings / Statement of purchases / sales

LAFARGE HOLCIM

Lafarge S.A. announces results of its tender offer for US$600,000,000 7.125% notes due 2036 - HTML (w)

2019.03.07 | 17:35 | Public offerings / Information note / Note in response

ROCHE

Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash - HTML (w)

2018.07.31 | 07:00 | Public offerings / Statement of purchases / sales

ROCHE

Roche Purchases Shares in Tender Offer for FMI - HTML (w)

2018.07.02 | 17:35 | Public offerings / Information note / Note in response

ROCHE

Roche commences tender offer for all shares of Foundation Medicine, Inc. for US$ 137.00 per share in cash - HTML (w)

More documents (38)